Y. Hernandez

Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, medRxiv.

Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, International Journal of Behavioral Medicine.

Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19

M. Peluso, Jeffrey N. Martin, T. Wrin, 2021, medRxiv.

Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, International Journal of Behavioral Medicine.

Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms

M. Peluso, Jeffrey N. Martin, T. Wrin, 2021, Cell Reports.

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

M. Peluso, Jeffrey N. Martin, T. Wrin, 2021, Science Advances.

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

12, M. Peluso, Jeffrey N. Martin, 2021, medRxiv.